GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,000 | +100.0% | 25,000 | +150.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -81.5% | 10,000 | -50.0% | 0.00% | -80.0% |
| Q1 2016 | $27,000 | +22.7% | 20,000 | +33.3% | 0.02% | +25.0% |
| Q4 2015 | $22,000 | -8.3% | 15,000 | 0.0% | 0.01% | +33.3% |
| Q3 2015 | $24,000 | -7.7% | 15,000 | 0.0% | 0.01% | -35.7% |
| Q2 2015 | $26,000 | +23.8% | 15,000 | 0.0% | 0.01% | +16.7% |
| Q1 2015 | $21,000 | -8.7% | 15,000 | 0.0% | 0.01% | -7.7% |
| Q4 2014 | $23,000 | -25.8% | 15,000 | 0.0% | 0.01% | -23.5% |
| Q3 2014 | $31,000 | -32.6% | 15,000 | 0.0% | 0.02% | -32.0% |
| Q2 2014 | $46,000 | -23.3% | 15,000 | +25.0% | 0.02% | -26.5% |
| Q4 2013 | $60,000 | +122.2% | 12,000 | 0.0% | 0.03% | +112.5% |
| Q3 2013 | $27,000 | 0.0% | 12,000 | 0.0% | 0.02% | -5.9% |
| Q2 2013 | $27,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |